Ars PharmaceuticalsSPRY
13F holders, Q2 2025 (June 30)187holders +4
27new positions
22sold out
6famous investors
$17.45avg. 13F price*
At the end of Q2 2025, 187 institutions reported holding Ars Pharmaceuticals Inc. (SPRY) in their 13F filings, up 4 from Q1 2025. 27 opened new positions and 22 sold out. The largest holders were Ra Capital Management, L.P. ($189.5M), Deerfield Management Company, L.P. ($169.7M) and Orbimed Advisors LLC ($144.6M). 6 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Joel Greenblatt (0.0% of Gotham Asset Management's portfolio).
- Company
- Ars Pharmaceuticals Inc.
- CUSIP
- 82835W108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 27 | $103.7M |
| Exits | 22 | $10.4M |
All 13F filers, Q1 2025 → Q2 2025: 14,431,580 shares bought and 6,075,804 shares sold, net +8,355,776 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 187 holders
| Ra Capital Management, L.P. | 3.19% | No change | 10,860,977 | $189.5M |
| Deerfield Management Company, L.P. | 3.44% | Reduce -7.5% | 9,724,508 | $169.7M |
| Orbimed Advisors LLC | 3.64% | No change | 8,288,510 | $144.6M |
| BlackRock, Inc. | 0.00% | Add +2.9% | 4,423,464 | $77.2M |
| SR One Capital Management, LP | 15.18% | No change | 4,012,903 | $70.0M |
| Alliancebernstein L.P. | 0.02% | Reduce -2.5% | 3,825,793 | $66.8M |
| Vanguard Group Inc. | 0.00% | Reduce -6.5% | 3,262,673 | $56.9M |
| Citadel Advisors | 0.03% | Add +179.8% | 2,242,176 | $39.1M |
| State Street Corp. | 0.00% | Add +8.0% | 2,194,493 | $38.3M |
| Franklin Resources Inc. | 0.01% | Reduce -1.6% | 1,828,755 | $31.9M |
| Adage Capital Partners Gp, L.L.C. | 0.05% | New | 1,728,000 | $30.2M |
| Southpoint Capital Advisors LP | 0.75% | New | 1,709,069 | $29.8M |
| FMR LLC | 0.00% | Add +58.1% | 1,567,010 | $27.3M |
| Aberdeen Group plc | 0.04% | Add +49.9% | 1,502,575 | $26.2M |
| Goldman Sachs Group Inc. | 0.00% | Add +104.0% | 1,464,312 | $25.6M |
| Wellington Management Group LLP | 0.00% | Add +987.6% | 1,433,187 | $25.0M |
| Octagon Capital Advisors LP | 5.17% | Add +116.0% | 1,350,000 | $23.6M |
| Geode Capital Management, LLC | 0.00% | Add +6.5% | 1,342,387 | $23.4M |
| MPM Bioimpact LLC | 3.94% | Reduce -0.7% | 1,303,399 | $22.7M |
| Rubric Capital Management LP | 0.36% | Add +25.8% | 1,294,878 | $22.6M |
| Cormorant Asset Management, LP | 1.43% | Reduce -31.3% | 1,100,000 | $19.2M |
| Millennium Management | 0.01% | Add +8.8% | 878,157 | $15.3M |
| UBS Group AG | 0.00% | Add +46.6% | 866,935 | $15.1M |
| Nextech Invest Ltd. | 2.45% | Reduce -20.8% | 741,729 | $12.9M |
| Raymond James Financial Inc. | 0.00% | Reduce -4.7% | 673,370 | $11.8M |
| Next Century Growth Investors LLC | 0.84% | New | 622,823 | $10.9M |
| Barclays PLC | 0.00% | Add +371.3% | 622,235 | $10.9M |
| Janney Montgomery Scott LLC | 0.03% | Add +31.8% | 591,425 | $10.3M |
| Northern Trust Corp. | 0.00% | Reduce -0.4% | 485,014 | $8.5M |
| Ardsley Advisory Partners LP | 1.35% | Add +46.1% | 475,000 | $8.3M |
| Driehaus Capital Management LLC | 0.06% | New | 464,030 | $8.1M |
| Peregrine Capital Management LLC | 0.24% | Reduce -8.9% | 456,979 | $8.0M |
| First Turn Management, LLC | 1.48% | Reduce -31.9% | 455,953 | $8.0M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +6.1% | 442,202 | $7.7M |
| Lisanti Capital Growth, LLC | 2.03% | Add +116.7% | 420,075 | $7.3M |
| Morgan Stanley | 0.00% | Reduce -13.3% | 383,616 | $6.7M |
| Wexford Capital LP | 1.86% | Reduce -6.4% | 382,555 | $6.7M |
| Ameriprise Financial Inc. | 0.00% | Add +231.4% | 345,055 | $6.0M |
| First Trust Advisors LP | 0.00% | New | 340,119 | $5.9M |
| Balyasny Asset Management L.P. | 0.01% | Add +92.3% | 329,073 | $5.7M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +16.4% | 325,645 | $5.7M |
| Bank of America Corp. | 0.00% | Reduce -26.8% | 325,352 | $5.7M |
| Neuberger Berman Group LLC | 0.00% | Add +2.4% | 324,877 | $5.7M |
| K2 Principal Fund, L.P. | 2.40% | Reduce -34.7% | 317,126 | $5.5M |
| Woodline Partners LP | 0.03% | Reduce -50.0% | 300,419 | $5.2M |
| Allspring Global Investments Holdings, LLC | 0.01% | Reduce -20.2% | 294,111 | $5.1M |
| Alyeska Investment Group, L.P. | 0.02% | No change | 290,092 | $5.1M |
| Levin Capital Strategies, L.P. | 0.50% | Reduce -75.2% | 289,147 | $5.0M |
| Susquehanna International Group, LLP | 0.01% | Add +25.8% | 256,966 | $4.5M |
| Royce & Associates LP | 0.05% | Reduce -60.1% | 256,269 | $4.5M |
| Nicholas Investment Partners, LP | 0.45% | Reduce -58.3% | 255,107 | $4.5M |
| Pictet Asset Management Holding SA | 0.00% | New | 234,841 | $4.3M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -3.8% | 180,492 | $3.1M |
| Voya Investment Management LLC | 0.00% | Add +152.9% | 166,184 | $2.9M |
| FAS Wealth Partners, Inc. | 0.19% | Add +6.9% | 149,160 | $2.6M |
| Bank of New York Mellon Corp | 0.00% | Add +9.8% | 145,117 | $2.5M |
| Avidity Partners Management LP | 0.49% | New | 140,000 | $2.4M |
| Nuveen, LLC | 0.00% | Reduce -9.9% | 139,133 | $2.4M |
| Steward Partners Investment Advisory, LLC | 0.02% | Add +164.4% | 128,180 | $2.2M |
| Invesco Ltd. | 0.00% | Add +292.3% | 117,500 | $2.1M |
| Hussman Strategic Advisors, Inc. | 0.42% | New | 105,000 | $1.8M |
| Legato Capital Management LLC | 0.22% | Add +7.8% | 104,133 | $1.8M |
| Royal Bank of Canada | 0.00% | Add +454.2% | 102,791 | $1.8M |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0.00% | New | 101,679 | $1.8M |
| New York State Common Retirement Fund | 0.00% | Add +28.2% | 93,298 | $1.6M |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +0.0% | 87,162 | $1.5M |
| Coastal Bridge Advisors, LLC | 0.13% | New | 87,025 | $1.5M |
| Sei Investments Co. | 0.00% | Reduce -10.5% | 85,082 | $1.5M |
| Swiss National Bank | 0.00% | Add +11.4% | 84,300 | $1.5M |
| Valley Forge Investment Consultants Inc. Adv | 0.47% | No change | 83,225 | $1.5M |
| Rhumbline Advisers | 0.00% | Add +16.5% | 81,261 | $1.4M |
| Rafferty Asset Management, LLC | 0.00% | Add +7.3% | 80,846 | $1.4M |
| Boothbay Fund Management, LLC | 0.04% | New | 75,458 | $1.3M |
| Epoch Investment Partners, Inc. | 0.01% | Reduce -38.8% | 72,780 | $1.3M |
| Janus Henderson Group PLC | 0.00% | Add +221.7% | 69,479 | $1.2M |
| Knights of Columbus Asset Advisors LLC | 0.07% | Add +57.8% | 68,094 | $1.2M |
| Sectoral Asset Management Inc. | 0.76% | Reduce -34.4% | 65,785 | $1.1M |
| CastleKnight Management LP | 0.08% | No change | 65,300 | $1.1M |
| Wells Fargo & Company | 0.00% | Add +2.5% | 61,106 | $1.1M |
| D. E. Shaw & Co. | 0.00% | Add +70.0% | 57,449 | $1.0M |
| AssuredPartners Investment Advisors, LLC | 0.24% | Reduce -17.6% | 56,969 | $994K |
| Matisse Capital | 0.47% | Add +1.8% | 56,714 | $990K |
| Harbour Capital Advisors, LLC | 0.20% | Add +102.3% | 57,950 | $971K |
| Principal Financial Group Inc. | 0.00% | New | 55,446 | $968K |
| Legal & General Group Plc | 0.00% | Add +55.1% | 54,825 | $957K |
| Alps Advisors Inc. | 0.01% | New | 53,000 | $925K |
| Miura Global Management, LLC | 0.94% | Reduce -33.3% | 50,000 | $873K |
| Aquatic Capital Management LLC | 0.02% | New | 48,688 | $850K |
| Gsa Capital Partners LLP | 0.06% | Add +64.8% | 45,252 | $790K |
| Quinn Opportunity Partners LLC | 0.07% | Reduce -59.7% | 45,000 | $785K |
| Schulhoff & Co. Inc. | 0.34% | Add +7.4% | 43,500 | $759K |
| Two Sigma Advisers, LP | 0.00% | Add +0.7% | 41,200 | $719K |
| Diker Management LLC | 0.67% | Add +95.2% | 41,000 | $715K |
| Sit Investment Associates Inc. | 0.01% | New | 40,350 | $704K |
| Baron Capital (BAMCO) | 0.00% | New | 40,000 | $698K |
| Marshall Wace, LLP | 0.00% | Reduce -74.5% | 39,914 | $697K |
| Mariner, LLC | 0.00% | Add +4.6% | 39,713 | $693K |
| Creative Planning | 0.00% | Add +13.5% | 37,604 | $656K |
| Citigroup Inc. | 0.00% | Reduce -60.5% | 37,583 | $656K |
| Deutsche Bank AG | 0.00% | Reduce -5.3% | 37,013 | $646K |
"% of holder's portfolio" is SPRY's weight in each manager's 13F, not the share of Ars Pharmaceuticals Inc. the manager owns.